An Overview of the Clinical Uses, Pharmacology, and Safety of Modafinil
Open accessAbstract
Modafinil (MOD) is a wakefulness-inducing compound prescribed for treatment of excessive daytime sleepiness as a consequence of sleep disturbances such as shift work sleep disorder, obstructive sleep apnea, restless leg syndrome, or narcolepsy. While providing effective results in patients with sleepiness, MOD also produces positive outcomes in the management of fatigue associated with different conditions including depression, cancer, or tiredness in military personnel. Although there is clear evidence of the stimulant effects of MOD, current data also show that administration of this drug apparently induces positive neurobiological effects, such as improvement in memory. However, serious concerns have been raised since some reports have suggested MOD dependence. Taken together, these findings highlight the need to characterize the changes induced by MOD which have been observed in several neurobiological functions. Moreover, further work should follow up on the likely long-term effects of this drug if used for treatment of drowsiness and tiredness. Here, we review and summarize recent findings of the medical uses of MOD in the management of sleepiness and fatigue associated with depression or cancer as well as exhaustion in military personnel. We also discuss the available literature related with the cognitive enhancing properties of this stimulant, as well as what is known and unknown about MOD addiction.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Evidence for topiramate in cocaine use disorder is mixed; a meta-analysis showed higher continuous stimulant abstinence over three weeks with topiramate versus placebo.
“The evidence for topiramate in cocaine use disorder outcomes is mixed; a meta-analysis demonstrated a higher rate of continuous stimulant abstinence over three weeks with topiramate versus placebo.114”
From The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (2024) · cites this paper as [114]
These studies generally noted a large beneficial effect of pharmacotherapy for both preexisting and stimulant-induced psychosis, as well as preexisting and stimulant-induced mania.
“These studies generally noted a large beneficial effect of pharmacotherapy for both preexisting and stimulant-induced psychosis, as well as preexisting and stimulant-induced mania.”
From The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (2024) · cites this paper as [114]
Almost all evidence for treating symptoms of psychosis from systematic reviews and meta-analyses is based on stimulant-induced or unspecified causes of psychosis.
“Almost all evidence for treating symptoms of psychosis from systematic reviews and meta-analyses is based on stimulant-induced or unspecified causes of psychosis.114,117,119,[150][151][152][153][154][155]”
From The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (2024) · cites this paper as [114]
Cites
Pharmacological treatments for fatigue associated with palliative care
Mücke, M., Mochamat, M., Cuhls, H., Peuckmann-Post, V., Minton, O., Stone, P., & Radbruch, L. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006788.pub3 · Cited by 227 · see citing works
Black, J. E., & Hirshkowitz, M. (2005) · Sleep · doi:10.1093/sleep/28.4.464 · Cited by 172 · see citing works
Fatigue on the flight deck: The consequences of sleep loss and the benefits of napping
Hartzler, B. M. (2014) · Accident Analysis & Prevention · doi:10.1016/j.aap.2013.10.010 · Cited by 166 · see citing works
Modafinil elicits sympathomedullary activation
Taneja, I., Diedrich, A., Black, B. K., Byrne, D. W., Paranjape, S. Y., & Robertson, D. (2005) · Hypertension · doi:10.1161/01.hyp.0000158267.66763.63 · Cited by 68 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Cancer-Related Fatigue: Causes and Current Treatment Options
Thong, M. S. Y., van Noorden, C. J. F., Steindorf, K., & Arndt, V. (2020) · Current Treatment Options in Oncology · doi:10.1007/s11864-020-0707-5 · Cited by 438 · see citing works
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder
(2024) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001299 · Cited by 78 · see citing works
Noradrenergic α1-Adrenoceptor Actions in the Primate Dorsolateral Prefrontal Cortex
Datta, D., Yang, S.-T., Galvin, V. C., Solder, J., Luo, F., Morozov, Y. M., Arellano, J., Duque, A., Rakic, P., Arnsten, A. F. T., et al. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.2472-18.2019 · Cited by 44 · see citing works
- Authors
- Murillo-Rodríguez, E., Barciela Veras, A., Barbosa Rocha, N., Budde, H., & Machado, S.
- Affiliations
- Laboratorio de Neurociencias Moleculares e Integrativas, Escuela de Medicina División Ciencias de la Salud, Universidad Anáhuac Mayab, 97310 Mérida, Yucatán, México
- Intercontinental Neuroscience Research Group, Yucatán, México
- Reykjavík University (IS)
- Venue
- ACS Chemical Neuroscience
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-12-04
- Volume
- 9
- Issue
- 2
- Pages
- 151-158
- ISSN
- 1948-7193 (ISSN-L)
- OpenAlex
- W2767299082
- Cited by
- 91
- References
- 4
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 9 · 2023: 13 · 2022: 16 · 2021: 16 · 2020: 11 · 2019: 12 · 2018: 3
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- ACS Chemical Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Funders
- Consejo Nacional de Ciencia y Tecnolog?a (CN-17-19)
- University of California Institute for Mexico and the United States
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and Work-Related Fatigue
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neuroethics, Human Enhancement, Biomedical Innovations
- Keywords
- modafinil, wakefulness-promoting agents, excessive daytime sleepiness, shift work disorder, obstructive sleep apnea, restless legs syndrome, narcolepsy, fatigue, depression, cancer, military personnel, cognitive enhancement, memory, drug addiction, stimulants, pharmacology, drug safety
- MeSH terms
- Modafinil, Animals, Benzhydryl Compounds, Cognition, Humans, Sleep, Wakefulness-Promoting Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review